IRICoR, Centre of Excellence Commercialization of Research, announces that the company will attend BIOInternational Convention 2013. This conference is being held at the McCormick Place, Chicago Illinois April 22–25, 2013.
This conference attracts key pharmaceutical and biotechnology companies from around the Word. It gives to the participants an opportunity to learn about investment trends and meet with leading dealmakers, strategic partners in Life Sciences. Many participants from various Life Sciences sector will be attending this conference.
For more information about BIO International Convention 2013, click here : BIO International Convention
In order to plan a meeting with the IRICoR representatives during the conference, please contact Dr Steven Klein by email: firstname.lastname@example.org or Dr Nadine Beauger at : email@example.com
About IRICoR | Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is a non-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate from IRIC and Université de Montréal. IRICoR, as a Center of Excellence in Commercialization and Research, invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially-promising projects. For more information about IRICoR, please visit www.iricor.ca.
Steven Klein Ph.D., MBA
Business Development, Director
T +1 514 343.6647